Erectile Dysfunction and Diabetes Mellitus - Full Text View

Purpose

This study consists of filling out a questionnaire on possible erectile dysfunction.

Condition	Intervention
Diabetes Mellitus Erectile Dysfunction	Procedure: Filling out a questionnaire on the possible occurrence of erectile dysfunction

MedlinePlus related topics:

Diabetes Erectile Dysfunction

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective

Official Title:	Erectile Dysfunction and Diabetes Mellitus

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:

Documentation of the prevalence of erectile dysfunction in the diabetic convention
Increase the awareness of diabetologist for erectile dysfunction
Relation of erectile dysfunction with metabolic parameters
Relation of erectile dysfunction with sex steroids

Secondary Outcome Measures:

Adjustment of the systematic follow-up of diabetic complications.
Optimalisation of the healthcare for diabetic patients, so that the quality of life for male diabetic patients can be improved

Estimated Enrollment:	300
Study Start Date:	May 2005
Study Completion Date:	March 2007

Detailed Description:

Male diabetic patients who attend a diabetic routine year program visit will be asked to give their voluntary permission to fill out a questionnaire on possible erectile dysfunction.

The questionnaire consists of two parts: Part 1 is the IIEF (International Index of Erectile Function) questionnaire and Part 2 is an additional questionnaire. The included patients have to fill out these questionnaires two times; once at the beginning at a diabetic year program visit and a second time one year later at the next diabetic year program consultation.

The patients will also be asked to give their permission for using their results of the routine diabetic year program for scientific research.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Male diabetic patients
Age older than 18 years

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00134329

Locations


Belgium
	University Hospital Ghent
	Ghent, Belgium, 9000

Sponsors and Collaborators

University Hospital, Ghent

Investigators


Principal Investigator:	Guy T'Sjoen, MD	University Hospital, Ghent

More Information

Website University Hospital Ghent This link exits the ClinicalTrials.gov site

Study ID Numbers:	2005/096
First Received:	August 23, 2005
Last Updated:	December 19, 2007
ClinicalTrials.gov Identifier:	NCT00134329
Health Authority:	Belgium: Institutional Review Board

Study placed in the following topic categories:

Sexual Dysfunctions, Psychological

Sexual Dysfunction, Physiological

Metabolic Diseases

Mental Disorders

Diabetes Mellitus

Endocrine System Diseases

Endocrinopathy

Metabolic disorder

Genital Diseases, Male

Glucose Metabolism Disorders

Erectile Dysfunction

Additional relevant MeSH terms:

Sexual and Gender Disorders

ClinicalTrials.gov processed this record on October 17, 2008

Sponsored by:	University Hospital, Ghent
Information provided by:	University Hospital, Ghent
ClinicalTrials.gov Identifier:	NCT00134329